MGH Neuropathy Laboratory — Boston, Massachusetts

MGH Neuropathy Laboratory is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

MGH Neuropathy Laboratory has participated in 1 clinical trials.

Therapeutic areas: Familial Amyloid Polyneuropathy.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MGH Neuropathy Laboratory?

MGH Neuropathy Laboratory has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MGH Neuropathy Laboratory conducted?

MGH Neuropathy Laboratory has 1 clinical trials on record. Their work covers Familial Amyloid Polyneuropathy.

Is MGH Neuropathy Laboratory accredited by Crixeo Health?

MGH Neuropathy Laboratory has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MGH Neuropathy Laboratory?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.